Innovation Pharmaceuticals Inc (IPIX)

[SitTight]

New peer-reviewed Brilacidin publication: "Antifungal Activity of Brilacidin, a Nonpeptide Host Defense Molecule".

We studied brilacidin, an arylamide of this type, for its activity in vitro against fungi (40 clinical isolates, 20 species) that the World Health Organization has highlighted as problem human pathogens. We found antifungal activity at low concentrations for many pathogens, which indicates that further screening for activity, particularly in vivo, is justified to evaluate this compound, and other mimetics, as attractive leads for the development of effective antifungal agents

https://www.mdpi.com/2079-6382/13/5/405

Submission For "Antibiotics" received: 8 February 2024 / Revised: 16 April 2024 / Accepted: 17 April 2024 / Published: 28 April 2024

"Antibiotics"'s Impact Factor: 4.8 (2022); 5-Year Impact Factor: 4.9 (2022)